Delivery Order SPE2DB24D9222-SPE2DB24FAZDA

Award Date 5/23/24
Potential Completion Date 6/14/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of the pharmaceutical product Rituxan 500 mg/50 ml vial. The award, valued at $6,374.58, was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, which supports the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract has an ultimate completion date of September 15, 2023 and is a firm fixed-price...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $33,760.87 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Rituxan 500 mg/50 ml vial, a pharmaceutical product used in medical care. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract #SPE2DB23D4600082013, which has a ceiling value of up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,247.48 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $30,691.70, is for the delivery of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business. The $31,872.90 contract is for the delivery of 4562002706 - RITUXAN 500 MG/50 ML VIAL 50ML. The order has a completion date of September 18, 2023 and is not set aside. DMS Pharmaceutical Group is a pharmaceutical wholesaler that provides a wide range of branded and generic prescription drugs,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,829.40, is for the delivery of 4567090302 RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product, with a completion date of February 19, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency Troop Support Medical. The contract is for the delivery of the pharmaceutical product Rituxan (rituximab) 500 mg/50 ml vial. The award has a firm fixed price of $3,069.17 and a completion date of March 12, 2024. The contract is not set aside and is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $30,691.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Rituxan 500 mg/50 ml vials, with a completion date of February 21, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, with a potential value of up to $4,999,999. Through this contract, DMS Pharmaceutical Group...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $95,618.70 contract is for the delivery of Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Rituxan 500 mg/50 ml vial. The delivery order has a completion date of January 30, 2024 and a potential value of $3,069.17. This delivery order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group Inc. and the Defense Logistics Agency to provide a variety of pharmaceutical...
  • SPE2DB24D9222
    Indefinite Delivery Contract
  • SPE2DB24D9222-SPE2DB24FAZDA
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Rituxan 500 mg/50 ml vials. The award value is $6,138.34 and the ultimate completion date is June 14, 2024.

The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle under the SPE2DB program allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides a vast array of medications, including both common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 8/22/24, 3:19 PM